Haleh Armian is an experienced professional in biomedical innovation and business development with a focus on medical devices and diagnostics. Currently serving as the Director of Biomedical Innovation Ventures at Hoag Hospital since January 2021, Armian facilitates the development, clinical validation, and commercialization of biomedical innovations. Previously, Armian held the position of Head of Strategy and Business Development at Draper, where strategic and commercialization plans for advanced medical technologies were developed. Armian's background includes significant roles at Joslin Diabetes Center, CIMIT/Partners HealthCare, TIAX, and Arthur D. Little, showcasing a strong track record in managing innovative healthcare projects and programs. Armian holds an MS in Health Policy and Management from Harvard T.H. Chan School of Public Health and a BS in Marketing and Finance, cum laude, from Boston College Carroll School of Management.